Recently, participants were vaccinated in a Phase two Lassa vaccine trial in Abuja, Nigeria. The trial, known as IAVI C105, is sponsored by the organisation I work for, IAVI, funded by CEPI, and designed in consultations with Nigerian health institutions.
The post New Lassa vaccine trial puts African experts at the helm appeared first on The Guardian Nigeria News – Nigeria and World News.